Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment
Investigative and Clinical Urology · 2023
DOI: 10.4111/icu.20230187 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Investigative and Clinical Urology, 2023. Verfasst von Sang Hun Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Medical Device Development Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Urology, Seoul National University College of Medicine, Seoul, Korea. uromedi@naver.com.
ORCID-Profile: Sang Hun Song, Sangchul Lee
Förderung
- Korea Medical Device Development Fund
Zitieren
APA
Song, S. H., & Lee, S. (2023). Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20230187
Vancouver
Song SH, Lee S. Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment. Investigative and Clinical Urology. 2023. doi:10.4111/icu.20230187
BibTeX
@article{Song2023,
author = {Song, Sang Hun and Lee, Sangchul},
title = {Cytoreductive nephrectomy in the age of immunotherapy-based combination treatment},
journal = {Investigative and Clinical Urology},
year = {2023},
doi = {10.4111/icu.20230187}
}
EUVIMED